Education
About Us
Working with TipRanks
Follow Us
Fortress Biotech (FBIO)
NASDAQ:FBIO
Earnings Data
Report Date
Mar 26, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.35Last Year’s EPS
-0.17Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth driven by the successful launch of EMROSI, improved EBITDA, and expanding prescriber base. However, challenges remain with the decline in legacy product revenues and delays in health plan formulary adoption for EMROSI. Despite these issues, the company is optimistic about EMROSI's potential and future revenue growth.Company Guidance
Significant Revenue Growth
Journey Medical reported a 21% year-over-year revenue growth for Q3 2025, reaching $17.6 million compared to $14.9 million in Q3 2024.
EMROSI's Strong Performance
EMROSI contributed $4.9 million to the top line in Q3, an increase of 75% from Q2, with total prescription growth of approximately 146%.
Positive EBITDA Trends
Non-GAAP EBITDA improved by $500,000 year-over-year, with positive adjusted EBITDA of $1.7 million for Q3 2025, compared to $300,000 in Q3 2024.
Increased Prescriber Base for EMROSI
The number of unique EMROSI prescribers increased by approximately 50% to over 2,700, indicating a strong adoption among dermatologists.
Market Access Achievements
Over 100 million of the 187 million commercial lives currently have access to EMROSI, with plans to contract with the remaining major GPO early next year.
FBIO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
FBIO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 14, 2025 | $2.49 | $2.62 | +5.22% |
Aug 14, 2025 | $1.96 | $2.12 | +8.16% |
May 15, 2025 | $1.78 | $1.81 | +1.69% |
Mar 31, 2025 | $1.56 | $1.54 | -1.28% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Fortress Biotech (FBIO) report earnings?
Fortress Biotech (FBIO) is schdueled to report earning on Mar 26, 2026, TBA (Confirmed).
What is Fortress Biotech (FBIO) earnings time?
Fortress Biotech (FBIO) earnings time is at Mar 26, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is FBIO EPS forecast?
FBIO EPS forecast for the fiscal quarter 2025 (Q4) is -0.35.